BT01001
/ Beyang Therapeutics
- LARVOL DELTA
Home
Next
Prev
1 to 1
Of
1
Go to page
1
January 03, 2026
Study Evaluating Safety of BT01001 Ophthalmic Solution
(clinicaltrials.gov)
- P1 | N=32 | Recruiting | Sponsor: Beyang Therapeutics Co., Ltd.
New P1 trial • Ophthalmology
1 to 1
Of
1
Go to page
1